Author:
Publisher:
ISBN:
Category : Drug interactions
Languages : en
Pages : 1940
Book Description
Drug Interaction Facts
Drug Interaction Facts 2011
Author: David S. Tatro
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574393224
Category : Drug interactions
Languages : en
Pages : 0
Book Description
Drug Interaction Facts(tm) provides health professionals with a fast and accurate interaction screening tool, with over 18,000 monographs. In just seconds, potential interactions can be reviewed by class, generic drug, or trade name. Comprehensive information on drug/drug or drug/food interactions is provided in a unique and logical quick-reference format to enhance the speed and accuracy of therapeutic decision making. Drug Interaction Facts(tm) provides information on the onset, severity, and documentation of clinically significant interactions, including a review of their effects, mechanism, and management. Readers will also find discussion and assessment of the data used to document the interaction.
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574393224
Category : Drug interactions
Languages : en
Pages : 0
Book Description
Drug Interaction Facts(tm) provides health professionals with a fast and accurate interaction screening tool, with over 18,000 monographs. In just seconds, potential interactions can be reviewed by class, generic drug, or trade name. Comprehensive information on drug/drug or drug/food interactions is provided in a unique and logical quick-reference format to enhance the speed and accuracy of therapeutic decision making. Drug Interaction Facts(tm) provides information on the onset, severity, and documentation of clinically significant interactions, including a review of their effects, mechanism, and management. Readers will also find discussion and assessment of the data used to document the interaction.
Drug Facts and Comparisons
Author:
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 3782
Book Description
Comprehensive drug information reference source intended for health professionals. Arranged by therapeutic drug classes. Each entry (monograph) gives detailed information covering such topics as actions, adverse reactions, and overdosage. General index.
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 3782
Book Description
Comprehensive drug information reference source intended for health professionals. Arranged by therapeutic drug classes. Each entry (monograph) gives detailed information covering such topics as actions, adverse reactions, and overdosage. General index.
Drug Facts and Comparisons 2011
Author:
Publisher:
ISBN: 9781574393194
Category : Chemicals
Languages : en
Pages : 0
Book Description
Drug Facts and Comparisons contains up-to-date, comprehensive information on over 22,000 Rx and 6,000 OTC items grouped by therapeutic category for ease of comparison. The book answers questions about actions, indications and contraindications; warnings and precautions; interactions between drugs; adverse reactions; administration, dosage, and overdosage; and patient information. Comparisons provided include drug to drug; different dosage forms; name brands are compared to name brands and to generics. Facts and Comparisons are also given on Centers for Disease Control biologicals and antiparasitic drugs; IV solutions; therapeutic and diagnostic ophthalmic preparations; diagnostic aids and radiographic contrast media and products; NCI investigational chemotherapeutic drugs; and combination cancer chemotherapy regimens. This hardbound edition includes the Drug Identifier 2011 CD-ROM, the premier tool for correct drug identification. Ensure accuracy by searching through more than 5,000 color images in seconds. Search by drug name, imprint, NDC code, color, shape, manufacturer, coating, scoring, clarity, and flavor.
Publisher:
ISBN: 9781574393194
Category : Chemicals
Languages : en
Pages : 0
Book Description
Drug Facts and Comparisons contains up-to-date, comprehensive information on over 22,000 Rx and 6,000 OTC items grouped by therapeutic category for ease of comparison. The book answers questions about actions, indications and contraindications; warnings and precautions; interactions between drugs; adverse reactions; administration, dosage, and overdosage; and patient information. Comparisons provided include drug to drug; different dosage forms; name brands are compared to name brands and to generics. Facts and Comparisons are also given on Centers for Disease Control biologicals and antiparasitic drugs; IV solutions; therapeutic and diagnostic ophthalmic preparations; diagnostic aids and radiographic contrast media and products; NCI investigational chemotherapeutic drugs; and combination cancer chemotherapy regimens. This hardbound edition includes the Drug Identifier 2011 CD-ROM, the premier tool for correct drug identification. Ensure accuracy by searching through more than 5,000 color images in seconds. Search by drug name, imprint, NDC code, color, shape, manufacturer, coating, scoring, clarity, and flavor.
Drug Information Handbook
Author: Charles F. Lacy
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 1836
Book Description
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 1836
Book Description
Martindale
Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309672104
Category : Medical
Languages : en
Pages : 427
Book Description
Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.
Publisher: National Academies Press
ISBN: 0309672104
Category : Medical
Languages : en
Pages : 427
Book Description
Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.
Drug Interaction Facts 2014
Author: David S. Tatro
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574393545
Category : Drug interactions
Languages : en
Pages : 0
Book Description
Reviewed by a panel of physicians, pharmacologists, and clinical pharmacists, it includes over 2,220 monographs with interaction information for over 20,000 brand name and generic drugs. Review potential interactions by class or generic/trade names; onset, severity, and clinically significant interaction data are provided along with effects, mechanisms, and management options. This handbook also introduces over 200 new and revised monographs in the 2014 edition.
Publisher: Lippincott Williams & Wilkins
ISBN: 9781574393545
Category : Drug interactions
Languages : en
Pages : 0
Book Description
Reviewed by a panel of physicians, pharmacologists, and clinical pharmacists, it includes over 2,220 monographs with interaction information for over 20,000 brand name and generic drugs. Review potential interactions by class or generic/trade names; onset, severity, and clinically significant interaction data are provided along with effects, mechanisms, and management options. This handbook also introduces over 200 new and revised monographs in the 2014 edition.
The Review of Natural Products
Author: Ara DerMarderosian
Publisher:
ISBN: 9781574392258
Category : Materia medica
Languages : en
Pages : 0
Book Description
The Review of Natural Products is the foremost source of current natural product information for health care professionals. More than 300 in-depth monographs are included, based on scientific research, not just anecdotal information. The Review of Natural Products provides detailed information about natural products, including their botany, history, chemistry, pharmacology, medicinal uses, toxicology, and patient information. It also includes significantly documented drug interactions.
Publisher:
ISBN: 9781574392258
Category : Materia medica
Languages : en
Pages : 0
Book Description
The Review of Natural Products is the foremost source of current natural product information for health care professionals. More than 300 in-depth monographs are included, based on scientific research, not just anecdotal information. The Review of Natural Products provides detailed information about natural products, including their botany, history, chemistry, pharmacology, medicinal uses, toxicology, and patient information. It also includes significantly documented drug interactions.
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.